Second consensus on medical treatment of metastatic breast cancer

Beslija, S.
Bonneterre, J.
Burstein, H.
Cocquyt, V.
Gnant, M.
Goodwin, P.
Heinemann, V.
Jassem, J.
Köstler, W. J.
Krainer, M.
Menard, S.
Petit, T.
Petruzelka, L.
Possinger, K.
Schmid, P.
Stadtmauer, E.
Stockler, M.
Van Belle, S.
Vogel, C.
Wilcken, N.
Wiltschke, C.
Zielinski, C. C.
Zwierzina, H.

Central European Cooperative Oncology Group (CECOG)^§, Schwarzspanierstrasse 7/5, A-1090 Vienna, Austria

Received 20 February 2006; revised 26 May 2006; accepted 26 May 2006

^*Correspondence to: Prof. C. C. Zielinski, Director, Department of Medicine I and Clinical Division of Oncology, Medical University of Vienna, 18–20 Waehringer Guertel, A – 1090 Vienna, Austria. Tel: +43 (1) 40400–4445; Fax: +43 (1) 440400–4451; E-mail: [email protected]

^§Affiliations of individual authors are provided in the Appendix.

Annals of Oncology 18(2):p 215-225, February 2007.

The present consensus manuscript defines evidence-based recommendations for state-of-the-art treatment of metastatic breast cancer depending on disease-associated and biologic variables.